NASA’s Efforts to Manage Health and Human Performance Risks for Space Exploration, NASA OIG “Although NASA continues to improve its process for identifying and managing health and human performance risks associated with space flight, we believe that given the current state of knowledge, the Agency’s risk mitigation schedule is optimistic and NASA will not develop countermeasures for many deep space risks until the 2030s, at the earliest.”

NASA Should Use an Ethics Framework When Making Decisions About Health Standards For Long Duration and Exploration Spaceflights “NASA should use an ethics framework when deciding whether, and under what conditions, spaceflights that venture outside low Earth orbit or extend beyond 30 days are acceptable if they do not meet current health standards, says a new report from the Institute of Medicine, the health arm of the National Academy of Sciences.”

NASA Signs Agreement to Develop Nasal Spray for Motion Sickness, NASA (with full text of Space Act Agreement) “Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With a […]